How does the protein content in meals influence post prandial bood glucose levels in individuals with type 1 diabetes mellitus?
Not Applicable
- Conditions
- Type 1 diabetes mellitusMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12613000215729
- Lead Sponsor
- ovo Nordisk pharmaceuticals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
Type 1 diabetes mellitus
HbA1c <8.5%
BMI < 91st centile
No other medical conditions
Diabetes for > 6 months
Using multiple daily injections or insulin pump therapy
Exclusion Criteria
HbA1c >8.5%
BMI > 91st centile
Other co-exisiting medical conditions
Complications of diabetes
Onset of diabetes <6 months
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome will be measured using the data from the CGM trace. <br>The primary outcome will be the glucose excursion at 8 hours after the test meal of protein.[8 hours after the test meal is consumed]
- Secondary Outcome Measures
Name Time Method The rate of maximal BGL increase every hour up to 8 hours post prandial. [8 hours after the test meal is consumed];The time it takes for the BGL to reach maximum excursion as measured by the CGM[Up to 8 hours following the test meal]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link dietary protein intake to postprandial glucose variability in Type 1 diabetes?
How does protein-containing meal timing compare to standard bolus insulin regimens for glucose control in ACTRN12613000215729?
Which biomarkers correlate with differential postprandial glucose responses to protein-rich meals in T1D patients?
What adverse metabolic effects are associated with high-protein diets in Novo Nordisk's Type 1 diabetes observational studies?
How do protein-based meal strategies compare to GLP-1 receptor agonists in managing postprandial hyperglycemia in T1D?